Scholar Rock Holding Corp at Barclays Global Healthcare Conference Transcript
Good morning, everyone. My name is Etzer Darout, Senior Biotech Analyst at Barclays. It's my pleasure to have Scholar Rock with us this morning. With us on stage, we have David Hallal, Chief Executive Officer and Chairman at Scholar Rock. David, thank you for joining us this morning. I'm sure most folks are familiar with the Scholar Rock story, but maybe just to help those that are not, just a brief introduction some introductory remarks would be great.
Thanks, Etzer. So Scholar Rock is a biotech company that this year will celebrate our 15th anniversary. We were formed with some highly innovative technology out of Tim Springer and Leonard Zonâs lab back in 2012. The focus of this was to develop antibody technology to block otherwise difficultâtoâinhibit growth factors in the body, largely around a family of growth factors and proteins, and through this technology we've been able to target some prior, very difficult
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
